Vyome

formerly Vyome Biosciences

Novel therapeutics for antibiotic-resistant acne and dermatological diseases

Delhi, India · Founded 2010 · $49.7M raised

Headquarters
Delhi
Employees
11–50
Founded
2010
Business Model
B2B
Total Funding
$49.7M
Last Round
Series DJan 2019
Rounds
7

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

About

Vyome Holdings was founded with a simple but ambitious vision: to tackle the hardest problems in healthcare — those overlooked, underserved, or resistant to existing treatments. What began as a biotech company focused on immuno-inflammatory disease has grown into a diversified healthcare platform spanning pharma, medical devices, and AI in healthcare. With a presence in both the United States and India, the company unites researchers, operators, and investors around creating therapies and technologies for patients.

Summary

Vyome is a Biotech company based in Delhi, India, founded in 2010. It has raised $49.7M in total across 7 rounds, most recently a Series D round in Jan 2019. Investors include Iron Pillar, Perceptive Advisors and Romulus Capital.

Funding History

Secondary MarketSeries D Secondary ComponentJan 2019

Sign up to see all 8 events

Funding: Series A through Series D. Amounts, valuations, and investors where available.

Investors

Similar Companies

Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017
BeiGeneIPO

BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...

Cambridge, United States10001+Biotech, Oncology
Corporate RoundTotal funding$2.8BJan 2020
BridgeBioIPO

BridgeBio develops treatments for genetic conditions through autonomous condition-focused teams s...

San Francisco Bay Area, United States201–500Biotech, Healthcare
Growth EquityTotal funding$2.7BJul 2026

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Vyome on Indexed.vc
<a href="https://indexed.vc/companies/vyome"><img src="https://indexed.vc/api/badge/company/vyome" alt="Vyome on Indexed.vc" width="260" height="76" /></a>